The Medicines and Healthcare products Regulatory Agency (MHRA), the agency responsible for ensuring that medicines work and are safe, is organising a online meeting on Wednesday 31 March from 10:00 – 11:30am […]

Now that most people in the Clinically Extremely Vulnerable Group have been vaccinated, it’s vital that we report any side effects from the vaccines. This is even more important for […]

Following the publication of emerging evidence that the Pfizer COVID vaccines are less effective for cancer patients after a single dose, the Blood Cancer Alliance (BCA) has today written to […]

Shielding guidance for those who are clinically extremely vulnerable from COVID-19 – from the Department of Health and Social Care. See below for the latest advice to patients by the […]

Patients with blood cancers such as leukaemia vary in their immune response to COVID-19 and can struggle to clear infection for very many weeks, according to new research published in Cancer […]

Research FOR Patients -For an informed and empowered opinion- Have you made your clinical paper accessible yet? TP53 gene mutations or chromosome 17 loss which results in TP53 deletion is […]

Dear MDS UK members, We hope you have been coping as best as possible during this very difficult year for everyone. From the many phone calls and emails we have […]

Christmas Poem 2020 – by Kate D. A tradition of traditions that once a year consumes us with Nutcracker images, ginger and spice, stockings and F.C., a decorated tree. But […]

Welcome to our “#20for20 Charity Shop”. This is the place where our amazing fundraisers are swapping things for donations! What an excellent way to support MDS UK! How does it […]